iShares 1 3 Year Treasury Bond ETF vs Tempus AI — how do they compare? iShares 1 3 Year Treasury Bond ETF trades at $81.21 (market cap $26.63B), while Tempus AI trades at $70.05 (market cap $12.77B). The key difference: iShares 1 3 Year Treasury Bond ETF is far larger — about 2.1× Tempus AI's market cap, and Tempus AI is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 1 3 Year Treasury Bond ETF for 63 Days and Tempus AI for 22 Days on average.
| SHY | TEM | |
|---|---|---|
Market Cap | $26.63B | $12.77B |
Volume | 4,081,431 | 8,980,490 |
Sector | Fixed Income | Broad Market / Factor |
52-Week High | $83.18 | $99.28 |
52-Week Low | $81.05 | $41.55 |
Typical Hold Time | 63 Days | 22 Days |
Enterprise Value | — | $13.40B |
Signals from Pluang's Aura AI — not financial advice
SHY is trading at $81.16 with minimal daily movement (+0.04%), showing stability amid broader bond market volatility. The technical picture remains bearish with moving averages signaling downward pressure, while oscillators suggest neutral momentum. Recent corporate actions include consistent dividend payments, with the latest being $0.24 per share. The fund operates in a challenging interest rate environment where short-term bond ETFs face both opportunities and headwinds from Federal Reserve policy shifts.
The outlook for SHY is mixed, with potential benefits from rising short-term yields but significant pressure from the ongoing bond market selloff. Investment opportunities include exposure to increasing interest rates with limited duration risk, while risks encompass continued bond market volatility and macroeconomic uncertainty driving yields higher. The fund's stability and dividend consistency provide some defensive characteristics in turbulent markets.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →